On the initiative of Legal SIG members from ETH Zurich, ASTP members interested in reviving the Legal SIG met during ASTP’s Annual Conference in Seville in May 2024.
Achim Krebs discusses strategies for effective collaboration with patent attorneys, focusing on clear invention disclosures, realistic claim scopes, and strong inventor-attorney partnerships to…
Koen Verhoef examines the complexities of data use by AI and ML companies. He addresses ethical dilemmas, legal considerations, and the value of quality datasets, emphasising the need for clear…
Freddy Guemeni, Head of IP Services at the University of Manchester Innovation Factory, shares insights at New Professionals SIG #7. With over 10 years of experience in intellectual property…
The New Professionals SIG hosts a session on careers in knowledge transfer, featuring Monique Liddar's insights on intellectual property management, innovation, and laboratory setup. The event…
Jason Teng, in his 2023 webinar Yes We Can’t: Making Sense of the Research Exemption in Patent Law, analyses European research exemptions. He contrasts national implementations, explores their…
Andrew Tingey, in his 2023 webinar Sub-licensing: Horror Scenarios and How to Avoid Them, explores challenges in sub-licensing agreements. He addresses royalty structures, tiered sub-licensing, and…
Andrew Tingey’s January 2023 webinar explores sub-licensing challenges, including royalty distribution, tiered agreements, and control mechanisms. He offers strategies to mitigate risks, ensure…
Session on ‘Intellectual Property and Protection/Licensing thereof in Technology Transfer’ from Denise Mayfield (Dykema) who discusses patenting challenges, strategies and the importance of well…
In the 2022 Tea with ASTP webinar, Alan Bentley and Kevin Leland discuss automating Material Transfer Agreements. They showcase Vanderbilt’s MTAShare platform and Bayer’s Testing4Ag program,…
Russell Smith, in his 2021 book The Three Dimensions of Entrepreneurship, introduces the New Standard Model (NSM) for business success. This framework integrates enterprise anatomy, environmental…
Jon Wulff explores key success factors for knowledge transfer, focusing on management's role and TTO operations. He discusses portfolio management strategies for individual innovations and entire…
The Towards a Reform of the Research Assessment System report highlights the need for systemic change in assessing research quality and impact. It proposes a European coalition to prioritise qualitative assessment, reduce reliance on metrics like journal impact factors, and promote open science,…
The Tea with ASTP session explores cost-effective patent procurement strategies for AMCs and research universities. The panel discusses building valuable IP portfolios, what corporations seek in…
The Tea with ASTP webinar (2021) explores student IP policies and processes, addressing broader challenges of academic IP ownership, shared ownership, and spin-out creation. It highlights the…
The 2021 webinar explores mediation in international IP and knowledge transfer disputes. Kathleen Paisley and Andrzej Gadkowski discuss WIPO Mediation Rules, highlighting its cost-effective,…
In the 2021 Tea with ASTP webinar, Pernille W. Gojkovic from HØIBERG discusses inventorship, emphasising the importance of accurately defining inventors based on conceptual contributions to patents.…
The Doing Business in the United States guide provides non-U.S. companies with key insights into establishing operations in the U.S. It covers legal, regulatory, and cultural considerations, entity formation, taxation, intellectual property, and employment laws to help companies navigate the…
Andrea Schmoll (2015) explores strategies to optimise licensing agreements, covering preparation, key provisions, and compliance with antitrust laws. Highlighting commercial and financial considerations, the presentation emphasises aligning agreements with IP protection, partner evaluation, and…
Mark Anderson (2012) provides guidance on structuring and drafting licence agreements. He addresses key clauses, risk allocation, performance obligations, and financial terms, emphasising precision in defining rights, responsibilities, and liabilities to ensure clarity and mitigate disputes.
Mark Anderson (2012) examines the drafting and negotiation of CTAs. He addresses key issues like regulatory compliance, intellectual property rights, liability, and indemnities, providing practical guidance on balancing stakeholder interests, ensuring clarity, and managing risks in clinical trial…
Mark Anderson (2009) provides detailed guidance on drafting and negotiating CTAs. He covers regulatory compliance, intellectual property, liability, and indemnities, emphasising clear contractual terms to balance stakeholder interests and navigate legal complexities effectively.
Jeremy Philpott (2012) discusses intellectual property strategies, focusing on patents and alternative protections. He explores when to use patents, strategic application considerations, and unregistered IP. Philpott emphasises commercial intentions, timing, and defensibility to maximise IP value…
Jeremy Philpott (2010) discusses leveraging intellectual property to support innovation. He covers strategic use of patents, trademarks, and unregistered IP, stressing the importance of aligning IP decisions with business goals, market timing, and effective resource management for competitive…
Mark Anderson (2010) provides detailed guidance on creating effective agreements. He addresses key issues like funding, intellectual property, liability, and governance structures, emphasising clarity, compliance, and balancing stakeholder interests to optimise collaborative research and…
The 2007 white paper Drug Discovery and Development: Understanding the R&D Process by the Pharmaceutical Research and Manufacturers of America outlines the complex and costly journey of developing new drugs. It emphasises collaboration, rigorous testing, and technological advancements required for…
The Responsible Partnering Guidelines (2009), developed by European institutional organisations, outline principles for effective collaboration and knowledge transfer between public research organisations and industry. It emphasises strategic alignment, IP management, mutual benefit, and…
The OECD Guidelines on Human Biobanks and Genetic Research Databases (2009) provide ethical, legal, and operational principles for managing biobanks. They address governance, participant rights, data protection, and benefit sharing, aiming to balance scientific progress with respect for individual…
The 2004 handbook Guidelines for Teaching Hospitals for Entering into Research Agreements by Danish teaching hospitals and universities provides frameworks for partnerships with private entities. It addresses IP rights, ethical considerations, confidentiality, and publication policies, promoting…
The OECD Guidelines for the Licensing of Genetic Inventions (2006) provide principles and best practices for managing genetic IP in healthcare. The document focuses on innovation promotion, equitable access, IP balance, and collaboration between public and private sectors to optimise healthcare and…
At the moment an invention is disclosed to the Technology Transfer Office (TTO), the totality of information needed for assessing the invention and possibly filing a patent is often distributed over several persons.
Joris Swennen and Sander Van Loock (2013) analyse key challenges in forming consortia. They address IP ownership, co-ownership, background access, and publication, emphasising clear communication, legal certainty, and tailored agreements to balance academic and industry interests effectively.
This free IP Teaching Kit of the EPO provides academic teaching staff with a unique collection of PowerPoint slides, speaking notes and background information on all the main types of intellectual property (IP).
The Lambert Toolkit has been prepared by the Lambert Working Group on Intellectual Property for universities and companies that wish to undertake collaborative research projects with each other.
The Research and Innovation Services of the University of Dundee has developed incoming and outgoing MTA forms that researchers need to fill out in order to make sure that the technology transfer services are well informed when processing the MTA’s.
Money has no smell. However, within the market there are different types of venture capitalist, which vary in terms of amount of capital invested per participation, management style and objectives, requirements with respect to the company management team, etc.
Joint ownership often arises in connection with collaborative innovation and is of particular relevance to EU-funded programmes, joint ventures and more generally to any research project involving the co-development of intellectual property (IP).
More and more innovation is driven by research collaborations between different entities. Within the context of globalized economy, these research and innovation collaborations are becoming increasingly internationalised.
Though the scale and substance of collaborations varies, a basic understanding of intellectual property rights (IPR) within the Chinese context may help to maximize the success of joint cooperation.
Samples of human biological material are used for many purposes and are of increasing importance as the funders of research, whether public, charitable or commercial, prioritise areas which rely upon access to human biological samples.
PROvendis has its origins in the innovation consulting firm Zenit GmbH. Founded in 1984, ZENIT is a Public Private Partnership owned by the State of North Rhine- Westphalia, a consortium of banks and an association comprising some 180 enterprises.
Founded in 2001 as a wholly-owned subsidiary of the LifeScience Foundation, Ascenion is a technology transfer company focusing on the field of life sciences. It currently serves a total of 23 research institutes and university hospitals all over Germany.
In order to assist its researchers in providing this information, KU Leuven Research & Development (technology transfer office of KU Leuven) has developed a mandatory Patent Inventor Form.
This document starts from the observation that in tandem with rapid advances in biotechnology research having valuable applications for use in healthcare the Canadian technology transfer activity has grown significantly.
While the IP Office recognizes that the specifics of any start-up company development may be unique, it has identified a number of common elements and the IP Office has developed standard mechanisms and support structures to assist with this process.
Join our newsletter and get the latest news
We will not disclose your information to any other parties
